Iran to supply devices to Sudan:
This article was originally published in Clinica
A letter of agreement has been signed by the governments of Iran and Sudan under which Iran will supply locally manufactured medical devices to Sudan. The agreement follows a visit to Iran in October by the Sudanese Health Minister, say local press reports.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.